AAAAAA

   
Results: 1-8 |
Results: 8
A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance
Authors: Advani, R Fisher, GA Lum, BL Hausdorff, J Halsey, J Litchman, M Sikic, BI
Citation: R. Advani et al., A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance, CLIN CANC R, 7(5), 2001, pp. 1221-1229
Long-term results of irradiation for patients with progressive Graves' ophthalmopathy
Authors: Marquez, SD Lum, BL McDougall, IR Katkuri, S Levin, PS MacManus, M Donaldson, SS
Citation: Sd. Marquez et al., Long-term results of irradiation for patients with progressive Graves' ophthalmopathy, INT J RAD O, 51(3), 2001, pp. 766-774
Primary leiomyosarcoma of the vagina. A case report and literature review
Authors: Ciaravino, G Kapp, DS Vela, AM Fulton, RS Lum, BL Teng, NNH Roberts, JA
Citation: G. Ciaravino et al., Primary leiomyosarcoma of the vagina. A case report and literature review, INT J GYN C, 10(4), 2000, pp. 340-347
Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance
Authors: Lum, BL Kaubisch, S Fisher, GA Brown, BW Sikic, BI
Citation: Bl. Lum et al., Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance, CANC CHEMOT, 45(4), 2000, pp. 305-311
A phase I single-dose trial of Gadolinium Texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging
Authors: Rosenthal, DI Nurenberg, P Becerra, CR Frenkel, EP Carbone, DP Lum, BL Miller, R Engel, J Young, S Miles, D Renschler, MF
Citation: Di. Rosenthal et al., A phase I single-dose trial of Gadolinium Texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging, CLIN CANC R, 5(4), 1999, pp. 739-745
A graphic nomogram for warfarin dosage adjustment
Authors: Dalere, GM Coleman, RW Lum, BL
Citation: Gm. Dalere et al., A graphic nomogram for warfarin dosage adjustment, PHARMACOTHE, 19(4), 1999, pp. 461-467
Prediction of valproate serum concentrations in adult psychiatric patientsusing Bayesian model estimations with NPEM2 population pharmacokinetic parameters
Authors: Puentes, E Puzantian, T Lum, BL
Citation: E. Puentes et al., Prediction of valproate serum concentrations in adult psychiatric patientsusing Bayesian model estimations with NPEM2 population pharmacokinetic parameters, THER DRUG M, 21(3), 1999, pp. 351-354
Risperidone: Clinical outcome predictors and cost-effectiveness in a naturalistic setting
Authors: Finley, PR Sommer, BR Corbitt, JL Brunson, GH Lum, BL
Citation: Pr. Finley et al., Risperidone: Clinical outcome predictors and cost-effectiveness in a naturalistic setting, PSYCHOPH B, 34(1), 1998, pp. 75-81
Risultati: 1-8 |